Characteristics and Radionuclide Imaging Results of Patients with Malignant Adrenal Masses
| Patient no. | Age (y) | Sex | Adrenal lesion | Site | Size* (cm) | Norcholesterol | MIBG | FDG |
|---|---|---|---|---|---|---|---|---|
| 1 | 51 | F | Carcinoma | R | 12.0 | NA | + | + |
| 2 | 51 | M | Carcinoma | L | 6.5 | NA | NA | + |
| 3 | 58 | F | Carcinoma | L | 7.0 | NA | − | + |
| 4 | 28 | F | Carcinoma | L | 10.0 | NA | NA | + |
| 5 | 16 | F | Carcinoma | R | 4.5 | NA | NA | + |
| 6 | 41 | F | Carcinoma | R | 5.0 | − | NA | + |
| 7 | 73 | M | Sarcoma | L | 8.0 | NA | − | NA |
| 8 | 55 | M | Sarcoma | L | 15.0 | NA | NA | + |
| 9 | 32 | F | Sarcoma metastasis | R | 6.0 | NA | NA | + |
| 10 | 41 | M | Sarcoma metastasis | L | 3.5 | NA | − | NA |
| 11 | 65 | F | Melanoma metastasis | R | 4.5 | NA | NA | + |
| 12 | 31 | M | Colon cancer metastasis | R | 4.0 | NA | − | NA |
| 13 | 60 | M | Liver cancer metastasis | R | 13.0 | NA | NA | + |
| 14 | 68 | M | Lung cancer metastasis | L | 3.0 | NA | NA | + |
| 15 | 52 | M | Lung cancer metastasis | L | 2.0 | − | NA | NA |
| 16 | 47 | M | Lung cancer metastasis | R | 5.0 | NA | NA | + |
| 17 | 62 | M | Lung cancer metastasis | R | 5.0 | NA | NA | + |
| 18 | 63 | M | Lung cancer metastasis | L | 2.5 | − | NA | NA |
↵* Maximal diameter.
+ = increased tracer uptake by adrenal lesion (scan findings positive); − = no tracer uptake by adrenal lesion (scan findings negative); NA = not available.